James V. Caruso

2022

In 2022, James V. Caruso earned a total compensation of $1.5M as President and Chief Executive Officer at Cellectar Biosciences, a 32% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$277,225
Option Awards$616,697
Salary$569,250
Total$1,463,172

Caruso received $616.7K in option awards, accounting for 42% of the total pay in 2022.

Caruso also received $277.2K in non-equity incentive plan and $569.3K in salary.

Rankings

In 2022, James V. Caruso's compensation ranked 2,267th out of 5,690 executives tracked by ExecPay. In other words, Caruso earned more than 60.2% of executives.

ClassificationRankingPercentile
All
2,267
out of 5,690
60th
Division
Manufacturing
1,226
out of 3,095
60th
Major group
Chemicals And Allied Products
541
out of 1,406
62nd
Industry group
Drugs
496
out of 1,307
62nd
Industry
Pharmaceutical Preparations
359
out of 949
62nd
Source: SEC filing on April 26, 2024.

Caruso's colleagues

We found two more compensation records of executives who worked with James V. Caruso at Cellectar Biosciences in 2022.

2022

Jarrod Longcor

Cellectar Biosciences

Chief Operating Officer

2022

Chad Kolean

Cellectar Biosciences

Chief Financial Officer

News

You may also like